Newsroom - Page 8

Coverage of our peer-reviewed research in the healthcare and mainstream press.
Tumor response rate and progression-free survival were the benchmarks that helped pembrolizumab (Keytruda) gain accelerated approval as first-line treatment for metastatic nonsquamous non-small cell lung cancer (NSCLC), in combination with chemotherapy.
A cohort study of TRICARE patients found that those who began to use statins were more likely to be diagnosed with a back disorder.
The creator of the compromise that pushed the Obamacare replacement past its first hurdle withstood hours of jeers from angry constituents, as he tried to present the nuances of a plan to shore up the individual health insurance market.
A new study using “next generation” materials could offer solutions to the problems that have delayed smart lenses for blood glucose testing in diabetes care.
A new report from the Urban Institute seeks to characterize the rating regions across the United States by the number of insurers offering plans in the healthcare marketplaces and found stark disparities in demographics, coverage, and price.
While global inequalities for survival of childhood leukemia have narrowed, the gap remains wide for acute lymphoblastic leukemia and acute myeloid leukemia, according to a study published in The Lancet Haematology. In some countries, the 5-year survival rate is nearly twice as high as in others for children diagnosed in 2005-2009.
COPD Compendium
Diabetes Compendium
GI Compendium
Lipids Compendium
MACRA Compendium
Oncology Compendium
Rare Disease Compendium
Reimbursement Compendium
Know Your News
HF Compendium